Eli Lilly’s Alzheimer’s treatment Kisunla wins approval in Japan

Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer’s is the most common form of dementia, accounting for more than 67% of cases, according to Lilly.
Article Attribution | Read More at Article Source
The post Eli Lilly’s Alzheimer’s treatment Kisunla wins approval in Japan appeared first on RocketNews.